Cargando…

Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery

Detalles Bibliográficos
Autores principales:	Liu, Anding, Wang, Wenjie, Zhao, Xuecheng, Zhou, Xiaoxi, Yang, Dongliang, Lu, Mengji, Lv, Yongman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346807/ https://www.ncbi.nlm.nih.gov/pubmed/32653658 http://dx.doi.org/10.1016/j.cmi.2020.07.009

Ejemplares similares

Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
por: Liu, Anding, et al.
Publicado: (2020)

SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples
por: Zhao, Y., et al.
Publicado: (2020)

Disappearance of SARS-CoV-2 Antibodies in Infants Born to Women with COVID-19, Wuhan, China
por: Gao, Jinzhi, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
por: Yamayoshi, Seiya, et al.
Publicado: (2021)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in low-income university students
por: Araújo, Adriano Antunes de Souza, et al.
Publicado: (2021)

Antibody titers and protection against a SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Disimmune encephalopathy with onconeuronal antibodies in SARS-CoV-2 infected patients()
por: Saenz Lafourcade, Carolina, et al.
Publicado: (2021)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel
por: Addetia, Amin, et al.
Publicado: (2020)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients
por: He, Lu, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF
por: Andriuta, Daniela, et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

Characterising differential antibody response is integral to future SARS-CoV-2 serostudies
por: Pallett, Scott John Charles, et al.
Publicado: (2020)

SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies()
por: Pérez Álvarez, Á.I., et al.
Publicado: (2020)

Structure-based development of human antibody cocktails against SARS-CoV-2
por: Wang, Nan, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
por: Eisenhut, Katharina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

Tests for the Detection of Antibodies to SARS-CoV-2: Importance of the Critical Professional Interpretation
por: Mendicino, Diego A., et al.
Publicado: (2021)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
por: Salvagno, G.L., et al.
Publicado: (2022)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China
por: Zheng, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fnffbki2ovq9qqcqro77p3l0fb